• Mini symposia are forty-five minutes in length and limited to three speakers, each with fifteen minutes to speak, and fifteen minutes of chair or co-chair moderated discussion at the end of the session. (1 hour = 60 minutes)
• A chair and co-chair are required, one of the participants must be a CPDD Member. A chair or co-chair can be a speaker.
• The chair will submit the overall session title and summary abstract (maximum 250 words).
• Speakers will submit their individual presentation title only.

• Workshops are one hour and thirty minutes in length. (1.5 hours = 90 minutes)
• Workshops for the 2024 meeting will be scheduled primarily on Saturday, June 15, 2024.
• Workshops can have two-five speakers; one of the participants must be a CPDD Member.
• A co-chair and discussant are optional. A chair or co-chair can be a speaker.
• The chair will submit the overall session title and summary abstract (maximum 250 words).
• Speakers will submit their individual presentation title only.
• Workshops can consist of data presentations and/or skills-building opportunities and are expected to be more interactive than formal symposia. The chair will decide the speaking format and convey the concept to the speaking team.

• Forums are one hour in length. (1 hour = 60 minutes)
• Forum topics should be of broad general interest to meeting attendees (e.g., policy issues, funding of research). The chair will decide the speaking format and convey the concept to the speaking team.
• A co-chair and discussant are optional roles. A chair or co-chair can be a speaker.
• There must be two-five speakers presenting in the forum.
• The chair will submit the overall session title and summary abstract (maximum 250 words).
• Speakers will submit their individual presentation title only.

Oral/poster abstracts can be on any aspect of drug use disorder or addiction or on the actions of drugs of abuse. They should contribute to our knowledge of the agents involved in drug use disorder, including their molecular biology, chemistry, pharmacological action, biological disposition, abuse potential, safety or clinical usefulness. Contributions concerning research on neurobiology, epidemiology, prevention, public health aspects, or management and treatment of drug dependence are also encouraged.

An oral communication is a 15-minute talk in a topical session that is curated by the Program Committee.